AU2001249186A1 - Estrogen-regulated unconventional myosin-related protein: compositions and methods of use - Google Patents

Estrogen-regulated unconventional myosin-related protein: compositions and methods of use

Info

Publication number
AU2001249186A1
AU2001249186A1 AU2001249186A AU4918601A AU2001249186A1 AU 2001249186 A1 AU2001249186 A1 AU 2001249186A1 AU 2001249186 A AU2001249186 A AU 2001249186A AU 4918601 A AU4918601 A AU 4918601A AU 2001249186 A1 AU2001249186 A1 AU 2001249186A1
Authority
AU
Australia
Prior art keywords
estrogen
compositions
methods
related protein
unconventional myosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249186A
Other languages
English (en)
Inventor
Alan R. Brooks
Gary G. Deng
Gabor M. Rubanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2001249186A1 publication Critical patent/AU2001249186A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2001249186A 2000-03-10 2001-03-12 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use Abandoned AU2001249186A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18848800P 2000-03-10 2000-03-10
US60188488 2000-03-10
US09/803,126 US20020099190A1 (en) 2000-03-10 2001-03-09 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use
US09803126 2001-03-09
PCT/US2001/008060 WO2001068866A2 (fr) 2000-03-10 2001-03-12 Proteine non classique regulee par les oestrogenes apparentee a la myosine: compositions et methodes d'utilisation

Publications (1)

Publication Number Publication Date
AU2001249186A1 true AU2001249186A1 (en) 2001-09-24

Family

ID=26884126

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249186A Abandoned AU2001249186A1 (en) 2000-03-10 2001-03-12 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use

Country Status (5)

Country Link
US (1) US20020099190A1 (fr)
EP (1) EP1268539A2 (fr)
AU (1) AU2001249186A1 (fr)
NO (1) NO20024299L (fr)
WO (1) WO2001068866A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4409099A (en) * 1998-05-29 1999-12-13 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Also Published As

Publication number Publication date
US20020099190A1 (en) 2002-07-25
NO20024299D0 (no) 2002-09-09
WO2001068866A3 (fr) 2002-05-23
WO2001068866A2 (fr) 2001-09-20
NO20024299L (no) 2002-11-11
EP1268539A2 (fr) 2003-01-02

Similar Documents

Publication Publication Date Title
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
AU2609901A (en) Antimicrobial compositions and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2002367903A1 (en) Biologic-chemical herbicide compositions and methods of use
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001276461A1 (en) Cleaning compositions and their use
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2003241103A1 (en) Compositions containing anti-hiv peptides and methods of use
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2962400A (en) Cleaner composition and method of use thereof
AU2756301A (en) Compositions comprising genome segments and methods of using the same
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
WO2002077233A8 (fr) Methodes associees a 38650, 28472, 5495, 65507, 81588 et 14354, compositions de proteines humaines correspondantes et leurs utilisations
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2001271281A1 (en) Novel compositions for the expression of the human peptide histidine transporter1 and methods of use thereof
AU2001249186A1 (en) Estrogen-regulated unconventional myosin-related protein: compositions and methods of use
AUPQ760400A0 (en) Herbical formulations and methods of use thereof